JP2019529554A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019529554A5 JP2019529554A5 JP2019536698A JP2019536698A JP2019529554A5 JP 2019529554 A5 JP2019529554 A5 JP 2019529554A5 JP 2019536698 A JP2019536698 A JP 2019536698A JP 2019536698 A JP2019536698 A JP 2019536698A JP 2019529554 A5 JP2019529554 A5 JP 2019529554A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- met
- mutation
- pharmaceutical composition
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1616116.8A GB201616116D0 (en) | 2016-09-22 | 2016-09-22 | Use of c-Met inhibitors to treat cancers harbouring MET mutations |
| GB1616116.8 | 2016-09-22 | ||
| PCT/EP2017/073894 WO2018055029A1 (en) | 2016-09-22 | 2017-09-21 | Use of c-met inhibitors to treat cancers harbouring met mutations |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019529554A JP2019529554A (ja) | 2019-10-17 |
| JP2019529554A5 true JP2019529554A5 (enExample) | 2020-10-22 |
| JP7065858B2 JP7065858B2 (ja) | 2022-05-12 |
Family
ID=57539720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019536698A Active JP7065858B2 (ja) | 2016-09-22 | 2017-09-21 | ＭＥＴ突然変異を宿すがんを治療するためのｃ－Ｍｅｔ阻害剤の使用 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20190282570A1 (enExample) |
| EP (1) | EP3515418B1 (enExample) |
| JP (1) | JP7065858B2 (enExample) |
| CN (1) | CN109789108A (enExample) |
| CY (1) | CY1124668T1 (enExample) |
| DK (1) | DK3515418T3 (enExample) |
| ES (1) | ES2880085T3 (enExample) |
| GB (1) | GB201616116D0 (enExample) |
| HR (1) | HRP20210998T1 (enExample) |
| HU (1) | HUE054765T2 (enExample) |
| LT (1) | LT3515418T (enExample) |
| PL (1) | PL3515418T3 (enExample) |
| PT (1) | PT3515418T (enExample) |
| RS (1) | RS62084B1 (enExample) |
| SI (1) | SI3515418T1 (enExample) |
| SM (1) | SMT202100405T1 (enExample) |
| TW (1) | TWI784969B (enExample) |
| WO (1) | WO2018055029A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020100969A1 (ja) * | 2018-11-14 | 2020-05-22 | 学校法人金沢医科大学 | びまん性胃がんを治療するための医薬組成物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| BRPI0619424B1 (pt) * | 2005-12-05 | 2022-02-08 | Pfizer Products Inc | Uso de inibidores c-met/hgfrs para a fabricação de medicamentos |
| CL2007000851A1 (es) * | 2006-03-30 | 2008-03-14 | Novartis Ag | Anticuerpo anti receptor del factor de crecimiento del hepatocito (c-met); adn que codifican cadenas livianas y pesadas del anticuerpo; composicion farmaceutica y kit que comprenden dicho anticuerpo; metodo para tratar trastorno relacionado con c-met |
| RS61281B1 (sr) | 2009-12-31 | 2021-02-26 | Hutchison Medipharma Ltd | Sintetički intermedijer koristan u pripremi triazolopiridinskih c-met inhibitora |
-
2016
- 2016-09-22 GB GBGB1616116.8A patent/GB201616116D0/en not_active Ceased
-
2017
- 2017-09-21 SI SI201730818T patent/SI3515418T1/sl unknown
- 2017-09-21 EP EP17777211.8A patent/EP3515418B1/en active Active
- 2017-09-21 JP JP2019536698A patent/JP7065858B2/ja active Active
- 2017-09-21 DK DK17777211.8T patent/DK3515418T3/da active
- 2017-09-21 TW TW106132358A patent/TWI784969B/zh active
- 2017-09-21 US US16/335,697 patent/US20190282570A1/en not_active Abandoned
- 2017-09-21 LT LTEP17777211.8T patent/LT3515418T/lt unknown
- 2017-09-21 PT PT177772118T patent/PT3515418T/pt unknown
- 2017-09-21 RS RS20210854A patent/RS62084B1/sr unknown
- 2017-09-21 CN CN201780057297.7A patent/CN109789108A/zh active Pending
- 2017-09-21 PL PL17777211T patent/PL3515418T3/pl unknown
- 2017-09-21 HR HRP20210998TT patent/HRP20210998T1/hr unknown
- 2017-09-21 SM SM20210405T patent/SMT202100405T1/it unknown
- 2017-09-21 HU HUE17777211A patent/HUE054765T2/hu unknown
- 2017-09-21 WO PCT/EP2017/073894 patent/WO2018055029A1/en not_active Ceased
- 2017-09-21 ES ES17777211T patent/ES2880085T3/es active Active
-
2021
- 2021-07-13 CY CY20211100624T patent/CY1124668T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zorzi et al. | A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium | |
| ZA202103587B (en) | Compounds, pharmaceutical compositions, and methods of preparing compounds and of their use as atr kinase inhibitors | |
| JP2015523397A5 (enExample) | ||
| JP2016163571A5 (enExample) | ||
| FI3504187T3 (fi) | Pridopidiinin käyttö toiminnallisen heikkenemisen hoitoa varten | |
| JP2015536964A5 (enExample) | ||
| JP2017506624A5 (enExample) | ||
| RU2015121367A (ru) | Фармацевтическая комбинация, содержащая ингибитор b-raf и ингибитор деацетилазы гистонов, и ее применение при лечении пролиферативных заболеваний | |
| HK1206246A1 (en) | Use of high dose laquinimod for treating multiple sclerosis | |
| NZ714963A (en) | Compositions and methods for treating anemia | |
| JP2012515184A5 (enExample) | ||
| JP2019517542A5 (enExample) | ||
| JP2014525454A5 (enExample) | ||
| CY1106430T1 (el) | Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο | |
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2019530706A5 (enExample) | ||
| JP2015527374A5 (enExample) | ||
| JP2021504384A5 (enExample) | ||
| JP2016530238A5 (enExample) | ||
| WO2018005801A3 (en) | Novel non-systemic tgr5 agonists | |
| HRP20161147T1 (hr) | Farmaceutski sastav i postupak njegove proizvodnje | |
| PH12019500516A1 (en) | Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof | |
| JP2016505050A5 (enExample) | ||
| MX2014002817A (es) | Suspension oral. | |
| JP2014503589A5 (enExample) |